Wirksamkeit und Sicherheit von systemischer Psoriasis-Therapie bei viraler Hepatitis, Diabetes mellitus oder Niereninsuffizienz. Systematische Reviews

RLA Jakubzyk - 2023 - refubium.fu-berlin.de
Einleitung Diabetes mellitus (DM), virale Hepatitis (VH) und Niereninsuffizienz (NI) stellen
häufige Komorbiditäten (KM) bei Patient* Innen mit Psoriasis vulgaris (PSO) dar. Der …

Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: a systematic and critical review

S Langham, J Langham, HP Goertz… - BMC medical research …, 2011 - Springer
Background Observational studies, if conducted appropriately, play an important role in the
decision-making process providing invaluable information on effectiveness, patient-reported …

Risks of Biologic Therapy and the Importance of Multidisciplinary Approach for an Accurate Management of Patients with Moderate-Severe Psoriasis and Concomitant …

A Ion, AM Dorobanțu, LG Popa, MM Mihai, OA Orzan - Biology, 2022 - mdpi.com
Simple Summary Psoriasis is a chronic multisystem inflammatory disease associated with a
wide range of comorbidities including cardiovascular disease, hypertension, diabetes …

[PDF][PDF] Dorobant, u, AM; Popa, LG; Mihai, MM; Orzan, OA Risks of Biologic Therapy and the Importance of Multidisciplinary Approach for an Accurate Management of …

A Ion - 2022 - academia.edu
Psoriasis is a chronic multisystem inflammatory disease associated with a plethora of
comorbidities including metabolic syndrome, cardiovascular disease, hypertension …

Use of systemic therapies for treatment of psoriasis in people living with controlled HIV: inference-based guidance from a multidisciplinary expert panel

KA Papp, J Beecker, C Cooper, MG Kirchhof… - Dermatology and …, 2022 - Springer
Background People living with human immunodeficiency virus (PLHIV) have a similar
prevalence of psoriasis as the general population, though incidence and severity correlate …

Systemic pharmacological treatments for chronic plaque psoriasis: A Systematic Review and an Individual-Patient Data Network Meta-Analysis of Randomized …

R Guelimi - 2022 - osf.io
Psoriasis is a frequent immune-mediated disease with either skin or joint manifestations, or
both, which has a major impact on quality of life. Although there is currently no cure for …

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

K Reich, U Mrowietz, MA Radtke, D Thaci… - Archives of …, 2015 - Springer
Abstract The German Psoriasis Registry PsoBest was conducted in 2008 in order to
investigate the long-term outcomes and safety of systemic treatments for moderate-to-severe …

[HTML][HTML] Safety assessment of conventional and biological systemic therapy in older adults with psoriasis, a real-world multicentre cohort study

ELM Ter Haar, EE Ten Bruin… - Acta Dermato …, 2022 - ncbi.nlm.nih.gov
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due
to sparse evidence-based guidance. This multicentre retrospective study investigated the …

Indirect comparison of the effect of biologics in patients with psoriasis; A meta-analysis of randomized, double blind clinical trials in bayesian framework

V Brodszky, M Mo, L Gulacsi, P Baji… - Value in …, 2013 - valueinhealthjournal.com
Objectives The main aims of this systematic review were to identify all relevant literature on
clinical efficacy for biological medications in patients with psoriasis and to conduct an up-to …

[引用][C] Psoriasis: biologic treatment and liver disease

E Vilarrasa, L Puig - World J Dermatol, 2014